当前位置:首页 - 行情中心 - 鹿得医疗(920278) - 财务分析 - 现金流量表

鹿得医疗

(920278)

  

流通市值:6.15亿  总市值:10.87亿
流通股本:9864.53万   总股本:1.75亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金126,863,096.5865,317,203.95422,418,666.16332,050,144.44
  收到的税费返还16,519,630.239,021,296.4630,016,289.8725,965,083.79
  收到其他与经营活动有关的现金1,541,082.21,627,238.264,239,324.424,518,541.99
  经营活动现金流入小计144,923,809.0175,965,738.67456,674,280.45362,533,770.22
  购买商品、接受劳务支付的现金106,229,550.348,932,211.49201,098,853.04139,518,490.4
  支付给职工以及为职工支付的现金41,857,072.0521,426,364.8174,738,861.2455,855,882.35
  支付的各项税费3,336,741.71,648,924.929,451,394.697,467,994.69
  支付其他与经营活动有关的现金17,876,468.9210,576,612.1918,210,825.4127,433,241.68
  经营活动现金流出小计169,299,832.9782,584,113.41303,499,934.38230,275,609.12
  经营活动产生的现金流量净额-24,376,023.96-6,618,374.74153,174,346.07132,258,161.1
二、投资活动产生的现金流量:
  收回投资收到的现金773,338,579.78478,259,218.1801,451,487.66500,301,792.65
  取得投资收益收到的现金900,529.23391,903.774,189,043.493,459,815.91
  处置固定资产、无形资产和其他长期资产收回的现金净额2,340---
  收到的其他与投资活动有关的现金8,979,496.457,336,746.75,109,677.35-
  投资活动现金流入小计783,220,945.46485,987,868.57810,750,208.5503,761,608.56
  购建固定资产、无形资产和其他长期资产支付的现金18,726,162.1714,685,729.9143,217,448.4439,316,308.34
  投资支付的现金757,508,335.32427,331,741.75896,806,630580,322,161.07
  支付其他与投资活动有关的现金2,099,483.5---
  投资活动现金流出小计778,333,980.99442,017,471.66940,024,078.44619,638,469.41
  投资活动产生的现金流量净额4,886,964.4743,970,396.91-129,273,869.94-115,876,860.85
三、筹资活动产生的现金流量:
  取得借款收到的现金39,500,00029,500,00054,900,00054,900,000
  收到其他与筹资活动有关的现金--17,417.3914,089,173.8
  筹资活动现金流入小计39,500,00029,500,00054,917,417.3968,989,173.8
  偿还债务支付的现金43,910,00035,010,00030,790,00030,790,000
  分配股利、利润或偿付利息支付的现金412,161.07133,399.436,015,996.6135,612,877.55
  支付其他与筹资活动有关的现金900,000150,416.67450,0009,836,996.45
  筹资活动现金流出小计45,222,161.0735,293,816.0767,255,996.6176,239,874
  筹资活动产生的现金流量净额-5,722,161.07-5,793,816.07-12,338,579.22-7,250,700.2
四、汇率变动对现金及现金等价物的影响-1,154,040.58-701,590.38-778,854.33730,153.54
五、现金及现金等价物净增加额-26,365,261.1430,856,615.7210,783,042.589,860,753.59
  加:期初现金及现金等价物余额139,665,164.67139,665,164.67128,882,122.09128,882,122.09
  期末现金及现金等价物余额113,299,903.53170,521,780.39139,665,164.67138,742,875.68
补充资料:
  净利润3,457,248.32-19,220,537-
  资产减值准备339,521.86--436,102.41-
  固定资产和投资性房地产折旧4,103,283.88-6,630,610.24-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,103,283.88-6,630,610.24-
  无形资产摊销493,412.06-575,036.08-
  长期待摊费用摊销91,622.32-244,509.22-
  处置固定资产、无形资产和其他长期资产的损失--3,276.33-
  固定资产报废损失14,042.92---
  公允价值变动损失-1,089,981.49--440,882.65-
  财务费用1,777,769.19-2,650,452.08-
  投资损失-2,785,539.38--2,843,824.45-
  递延所得税-793,841.24--1,421.78-
  其中:递延所得税资产减少-793,841.24--1,421.78-
  存货的减少-4,759,793.5-4,241,545.78-
  经营性应收项目的减少5,119,582.69-59,383,074.8-
  经营性应付项目的增加-30,906,332.93-65,419,290.07-
  现金的期末余额113,299,903.53-139,665,164.67-
  减:现金的期初余额139,665,164.67-128,882,122.09-
  现金及现金等价物的净增加额-26,365,261.14-10,783,042.58-
公告日期2026-08-252026-04-282026-04-282025-10-29
审计意见(境内)标准无保留意见
TOP↑